Ipsen

Type: Public
On the web: http://www.ipsen.com

Ipsen develops pharmaceutical products that target oncology, endocrinology, and neuromuscular disorders. The group additionally markets products to treat gastroenterology, cardiovascular, and cognitive disorders. Ipsen operates research-and-development (R&D) centers in Paris, Boston, Barcelona, and London, which have churned out more than 20 products to the global therapeutic market. Its R&D efforts focus on peptide engineering, protein engineering, medicinal chemistry, and advanced drug delivery. The company markets its products directly as well as through third parties, and has formed strategic development alliances with the likes of Medicis and Applied Biosystems (now part of Life Technologies Corporation).

Key numbers for fiscal year ending December, 2008:
Sales: $1,463.2M
One year growth: 0.0%
Net income: $208.1M
Income growth: (6.4%)

Officers:
Chairman and CEO: Jean-Luc Bélingard
EVP and COO: Christophe Jean
EVP and CFO: Claire Giraut

Competitors:
Bayer AG
Novartis
Pfizer

Ipsen

Type
Founded	1929
Headquarters	Paris, France
Industry	Pharmaceutical
Products	Targeted therapeutic areas : oncology, endocrinology and neuromuscular disorders Primary care treatments (mainly in France): gastroenterology, cognitive disorders and cardiovascular
Employees	nearly 4,000
Website	www.ipsen.com

Ipsen is a French pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology, endocrinology and the treatment of neuromuscular disorders. In 2005, Ipsen spent € 169 million—20.9% of consolidated sales—on research and development, according to the IFRS.

v • d • e CAC Mid 100 companies of France (29 January, 2009) Alpes (Compagnie des)  · Alten  · Altran Technologies  · ANF  · April Group  · Areva  · Arkema  · Bains Mer Monaco  · Beneteau  · Bic  · BioMérieux  · Boiron  · Bolloré  · Bonduelle  · Bongrain  · Bourbon  · Boursorama  · Bureau Veritas  · Camaïeu  · Canal +  · Carbone Lorraine  · Cegedim  · Ciments français  · Club Méditerranée  · Delachaux  · Derichebourg  · EDF énergies nouvelles  · Esso  · Euler Hermes  · Eurazeo  · Eurofins Scientific  · Eutelsat Communications  · Faiveley  · Faurecia  · Fimalac  · Financière de l'Odet  · Foncière des Régions  · Foncière des Murs  · Gecina Nominatif  · Gemalto  · Groupe Eurotunnel  · Générale de Santé  · Groupe Steria  · Guerbet  · Guyenne et Gascogne  · Havas  · Icade  · Iliad  · Imerys  · Ingenico  · Ipsen  · Ipsos  · JCDecaux  · Kaufman & Broad S.A.  · Korian  · Laurent-Perrier  · LDC  · Legrand  · Lisi  · Manitou BF  · Maurel et Prom  · Mercialys  · Métropole TV  · Neopost  · Nexity  · Nicox  · Norbert Dentressangle  · NRJ Group  · ORPEA  · Pages Jaunes  · Pierre & Vacances  · Plastic Omnium  · Rallye  · Rémy Cointreau  · Rexel  · Rhodia  · Rubis  · SEB  · Saft  · Scór  · Séché Environnement  · Séchilienne-Sidec  · Sequana Capital  · Silic  · Sopra Group  · Sperian Protection  · Stallergenes  · STEF-TFE  · Teleperformance  · Theolia  · Thomson  · Ubisoft Entertainment  · Union Financière de France  · Valeo  · Vetoquinol  · Vicat  · Vilmorin Clause & Compagnie  · Virbac  · Wendel Investissement  · Zodiac

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)